Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of rimonabant on HbA1c in insulin-treated type 2 diabetes
2005-001613-17Phase 3Completed
- Sponsor
- Sanofi
- Start
- Nov 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing Rimonabant arm with Placebo arm (2 arms). Primary endpoint: Change in HbA1c. Started Nov 2005; status: completed.
02
Drugs
rimonabant
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2005-001613-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001613-17.